Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 3/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15529361 | 1.00 | LMNA (0.59) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL10702591 | 1.00 | LMNA (0.59) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL16672953 | 1.00 | LMNA (0.59) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL14445679 | 1.00 | LMNA (0.59) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL1345319 | 1.00 | LMNA (0.59) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL5605990 | 0.98 | LMNA (0.61) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL12064831 | 0.95 | LMNA (0.57) | LMNAALDH1A1MAPTRXFP1NPC1 | |
| SCHEMBL1051 | 0.93 | LMNA (0.68) | LMNAALDH1A1MAPTNPC1RECQL | |
| Acetic Acid Butyl Ester SCHEMBL11329285 | 0.89 | ALDH1A1 (0.55) | LMNAALDH1A1 | |
| SCHEMBL11929263 | 0.87 | TDP1 (0.62) | ALDH1A1MAPTRXFP1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060086048-A1 | Foam dentifrice composition and method | ROMLEY MICHAEL G | 2006-04-27 | — | — | US | claimed |
| CN-115057994-B | Olefin metathesis polymerization method based on diazonium monomer and polymer thereof | 安徽大学 | 2024-07-30 | — | — | CN | disclosed |
| EP-2869389-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME | MITSUBISHI CHEM CORP (JP) | 2019-11-13 | — | — | EP | disclosed |
| US-10320030-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-06-11 | — | — | US | disclosed |
| US-20150140448-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-05-21 | — | — | US | disclosed |
| EP-2869389-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | PLA2G1B, PLA2G4A, PLA2G4B | LMNA 622/4885ALDH1A1 1423/4885MAPT 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.